Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Michael Young who wrote (3533)	4/22/2001 8:31:35 PM
From: bosquedog	Respond to of 52153

Interesting that you bash her. She has an excellent track record. Why does she persist in using the word "ain't"?

To: Michael Young who wrote (3533)	4/23/2001 12:50:36 AM
From: Doc Bones	Respond to of 52153

This is Lissa's biography as supplied to an informed investors conference she addressed: informedinvestors.com Lissa Morgenthaler graduated from Princeton University with a degree in economics, including a senior thesis on venture capital. She has followed technology stocks since 1980, working with First Boston and Wookman, Kirkpatrick and Gilbreath. She joined the California Technology Stock Letter as a Senior Analyst in 1985. CTSL was the #1 stock letter in the Hulbert Financial Digest ratings in 1987 and for the three-year period 1987-89, and was #2 for the ten years ended 1996. She has specialized in biotechnology investing since 1990. In 1998 she joined Murphy Investment Management, Inc. as Portfolio Manager of the Murphy New World Biotechnology Fund. She is a frequent speaker at investment seminars and has appeared on CNBC, CNN and Wall Street With Louis Rukeyser. Her fund, MNWBX, is in fact one of those Rick is mocking in post #3506 Message 15698859 The fund's record: quote.yahoo.com So I'd have to say: "Rick, don't do it! Don't give all your money to the hedge funds! Stay with us!" <g> The public record of Rick and several other SI biotech posters is far beyond anything the Murphy Funds or newsletter(CTSL) ever did. Doc p.s. And I doubt that Cramer is much better.